Arylpiperazine derivatives of 3-propyl-β-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands

被引：0

作者：

Byrtus, H

Pawlowski, M

Duszynska, B

Wesolowska, A

Chojnacka-Wójcik, E

Bojarski, AJ

机构：

[1] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, PL-31343 Krakow, Poland

[2] Polish Acad Sci, Inst Pharmacol, Dept New Drug Res, PL-31343 Krakow, Poland

[3] Jagiellonian Univ, Coll Med, Dept Pharmaceut Chem, PL-30688 Krakow, Poland

来源：

POLISH JOURNAL OF PHARMACOLOGY | 2001年 / 53卷 / 04期

关键词：

1-arylpiperazine derivatives; 3-propyl-beta-tetralonohydantoins; 5-HT1A and 5-HT2A receptor affinity; structure-activity relationship;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A series of new analogues of 3-[3-(4-arylpiperazinyl)-propyl]-cyclohexane-1',5-spirohydantoin (2), with aromatic ring fused in amide moiety (4-9) were synthesized and evaluated for affinity at 5-HT1A and 5-HT2A receptors. The influence of the substitution mode in the phenyl ring of phenylpiperazine moiety on the affinity for both receptors has been discussed. The most potent 5-HT1A (9, K-i = 53 nM) and 5-HT2A (4, 6, 8 and 9; K-i = 14-76 nM) ligands were evaluated in in vivo tests. The obtained results indicate that all in vivo tested compounds showed pharmacological profile of 5-HT2A antagonists. Additionally, a m-CF3 derivative (9), behaved like a partial agonist (agonist of pre- and antagonist of postsynaptic) of 5-HT1A receptors and may offer a new lead for the development of potential psychotropic agents.

引用

页码：395 / 401

页数：7

共 50 条

[21] Synthesis of new 1,2,3-benzotriazin-4-one-arylpiperazine derivatives as 5-HT1A serotonin receptor ligands
Caliendo, G
Fiorino, F
Grieco, P
Perissutti, E
Santagada, V
Severino, B
Bruni, G
Romeo, MR
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (03) : 533 - 538
[22] The design and preparation of metabolically protected new arylpiperazine 5-HT1A ligands
Tandon, M
O'Donnell, MM
Porte, A
Vensel, D
Yang, DL
Palma, R
Beresford, A
Ashwell, MA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (07) : 1709 - 1712
[23] Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus
Fiorino, F.
Severino, B.
De Angelis, F.
Perissutti, E.
Magli, E.
Frecentese, F.
Esposito, A.
Massarelli, P.
Nencini, C.
Viti, B.
Santagada, V.
Caliendo, G.
PHARMAZIE, 2009, 64 (09): : 555 - 564
[24] Interaction of arylpiperazine ligands with the hydrophobic part of the 5-HT1A receptor binding site
Zlatovic, MV
Sukalovic, VV
Schneider, C
Roglic, GM
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (09) : 2994 - 3001
[25] Effects of 5-HT1A Receptor Antagonist and 5-HT2A Receptor Agonist on Morphine Withdrawal
Ramezani, Mahdi
Shahidi, Siamak
Afshar, Simin
Habibi, Parisa
Hashemi-Firouzi, Nasrin
NEUROCHEMICAL JOURNAL, 2024, 18 (02) : 321 - 330
[26] Altered 5-HT1A and 5-HT2A receptor interactions in anorexia and bulimia nervosa
Kaye, Walter H.
Bailer, U. F.
Frank, G. K.
Wagner, A.
Price, J. C.
Mathis, C. A.
Meltzer, C. C.
NEUROIMAGE, 2008, 41 : T155 - T155
[27] 9-substituted 1,2,3,4-tetrahydro-β-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands
Mokrosz, MJ
Boksa, J
Charakchieva-Minol, S
Wesolowska, A
Borycz, J
POLISH JOURNAL OF PHARMACOLOGY, 1999, 51 (04): : 351 - 356
[28] 1,2,3,4-tetrahydroisoquinoline derivatives:: A new class of 5-HT1A receptor ligands
Mokrosz, MJ
Bojarski, AJ
Duszynska, B
Tatarczynska, E
Klodzinska, A
Deren-Wesolek, A
Charakchieva-Minol, S
Chojnacka-Wojcik, E
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (02) : 287 - 295
[29] Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT2A Receptor by In Silico Methods
Lin, Feng
Li, Feng
Wang, Chao
Wang, Jinghui
Yang, Yinfeng
Yang, Ling
Li, Yan
MOLECULES, 2017, 22 (07):
[30] 3-(omega-aminoalkyl)-5,5-dialkyl (or spirocycloalkyl-1',5-)hydantoins as new 5-HT1A and 5-HT2A receptor ligands
Byrtus, H
Pawlowski, M
CharakchievaMinol, S
Duszynska, B
Mokrosz, MJ
Mokrosz, JL
Zejc, A
ARCHIV DER PHARMAZIE, 1996, 329 (06) : 283 - 290

← 1 2 3 4 5 →